Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet in therapy-refractory hyperparathyroidism in patients with chronic renal insufficiency (pilot study)
2005-004148-29Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cinacalcet in hyperparathyroidism and chronic kidney disease (CKD), sponsored by Medical University of Vienna. Primary endpoint: Reduction of PTH into target range. Started Nov 2005; status: completed.
02
Drugs
cinacalcet
03
Conditions
hyperparathyroidismchronic kidney disease (CKD)
Beyond the preview
Go deeper on 2005-004148-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004148-29.